Cargando…

Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir

[Image: see text] The SARS-CoV-2 replication and transcription complex (RTC) comprising nonstructural protein (nsp) 2–16 plays crucial roles in viral replication, reducing the efficacy of broad-spectrum nucleoside analog drugs such as remdesivir and evading innate immune responses. Most studies targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Ting, Fei, Cheng-Yin, Chen, Yi-Ping, Sargsyan, Karen, Chang, Chun-Ping, Yuan, Hanna S., Lim, Carmay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009100/ https://www.ncbi.nlm.nih.gov/pubmed/33855277 http://dx.doi.org/10.1021/acsptsci.1c00022

Ejemplares similares

Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir”
por: Chen, Ting, et al.
Publicado: (2021)

Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection
por: Saha, Tushar, et al.
Publicado: (2023)

Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors
por: Sargsyan, Karen, et al.
Publicado: (2020)

A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
por: Sargsyan, Karen, et al.
Publicado: (2023)

Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors
por: Ma, Chunlong, et al.
Publicado: (2020)

Correction: Multi-targeting of functional cysteines in multiple conserved SARS-CoV-2 domains by clinically safe Zn-ejectors
por: Sargsyan, Karen, et al.
Publicado: (2021)

The Assessment on Synergistic Activity of Ebselen and Silver Ion Against Yersinia pseudotuberculosis
por: Dong, Chuanjiang, et al.
Publicado: (2022)

Arrangement of 3D structural motifs in ribosomal RNA
por: Sargsyan, Karen, et al.
Publicado: (2010)

Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
por: Lo, Ho Sing, et al.
Publicado: (2021)

Ebselen and Diphenyl Diselenide Inhibit SARS-CoV-2 Replication at Non-Toxic Concentrations to Human Cell Lines
por: Wildner, Guilherme, et al.
Publicado: (2023)

The synergistic activity of SBC3 in combination with Ebselen against Escherichia coli infection
por: Chen, Hao, et al.
Publicado: (2022)

Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
por: Choy, Ka-Tim, et al.
Publicado: (2020)

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2
por: Hsu, Hsing-Yu, et al.
Publicado: (2021)

GeoPCA: a new tool for multivariate analysis of dihedral angles based on principal component geodesics
por: Sargsyan, Karen, et al.
Publicado: (2012)

GeoPCA: a new tool for multivariate analysis of dihedral angles based on principal component geodesics
por: Sargsyan, Karen, et al.
Publicado: (2015)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Hepatitis C Virus Protease Inhibitors Suppress Virus Replication and Act Synergistically with the SARS-CoV2 Polymerase Inhibitor Remdesivir
por: Bafna, Khushboo, et al.
Publicado: (2021)

Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication
por: Bravo, Jack P.K., et al.
Publicado: (2021)

Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
por: Sun, Le-Yun, et al.
Publicado: (2021)

Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
por: Menéndez, Cintia A., et al.
Publicado: (2020)

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
por: Amporndanai, Kangsa, et al.
Publicado: (2021)

Antibacterial Activity of Ebselen
por: Maślanka, Marta, et al.
Publicado: (2023)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections
por: Ko, Wen-Chien, et al.
Publicado: (2020)

Electrochemical Biosensor for the Detection of SARS-CoV-2 Main Protease and Its Inhibitor Ebselen
por: Zhang, Qiongyu, et al.
Publicado: (2022)

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents
por: Kannappan, Vinodh, et al.
Publicado: (2021)

Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir
por: Pohl, Marie O., et al.
Publicado: (2021)

Synergistic antibacterial effect of silver and ebselen against multidrug‐resistant Gram‐negative bacterial infections
por: Zou, Lili, et al.
Publicado: (2017)

Effects of ebselen and N-acetyl cysteine on replicative aging of primary human fibroblast strains
por: Marthandan, Shiva
Publicado: (2015)

Sequence-motif Detection of NAD(P)-binding Proteins: Discovery of a Unique Antibacterial Drug Target
por: Hua, Yun Hao, et al.
Publicado: (2014)

Remdesivir–ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2
por: Jeffreys, Laura N., et al.
Publicado: (2022)

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
por: Humeniuk, Rita, et al.
Publicado: (2021)

Identifying RNA-binding residues based on evolutionary conserved structural and energetic features
por: Chen, Yao Chi, et al.
Publicado: (2014)

Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases
por: Ou, An-te, et al.
Publicado: (2021)

Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report
por: Gidari, Anna, et al.
Publicado: (2023)

Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir
por: Camprubí, Daniel, et al.
Publicado: (2021)

Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
por: Lin, Min-Han, et al.
Publicado: (2018)

Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice
por: Wu, Meng-Li, et al.
Publicado: (2022)

The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus
por: Qiao, Zhen, et al.
Publicado: (2021)

Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease
por: Thun‐Hohenstein, Siegfried T. D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7mnasn39cu6r7kfuolrjfoqccg